Molecular role of Cx37 in advanced atherosclerosis: A micro-array study

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 69-76

  Derouette, Jean Paul ^a   Wong, Cindy ^a   Burnier, Laurent ^a,b   Morel, Sandrine ^a   Sutter, Esther ^a   Galan, Katia ^a   Brisset, Anne C ^a   Roth, Isabelle ^a   Chadjichristos, Christos E ^a   Kwak, Brenda R ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Atherosclerosis; Connexin; Gap junction; Matrix degradation; Plaque calcification; Tissue inflammation

Indexed keywords

ACTIN; ALPHA INTERFERON; CALPAIN; CASPASE; CONNEXIN 37; CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERLEUKIN 1; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEASOME; PROTEIN KINASE B; PROTEIN KINASE C; RNA POLYMERASE II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CELL INTERACTION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CALCINOSIS; CHOLESTEROL, DIETARY; CONNEXINS; GENE EXPRESSION PROFILING; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 68949204375     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.02.020     Document Type: Article

References (34)

1. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25 (2005) 2054-2061
2. Libby P., and Theroux P. Pathophysiology of coronary artery disease. Circulation 111 (2005) 3481-3488
3. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86 (2006) 515-581
4. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85 (2005) 1-31
5. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
6. Wong C.W., Christen T., Roth I., et al. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 12 (2006) 950-954
7. Saez J.C., Berthoud V.M., Branes M.C., Martinez A.D., and Beyer E.C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 83 (2003) 1359-1400
8. Chanson M., Derouette J.P., Roth I., et al. Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta 1711 (2005) 197-207
9. Herve J.C., Bourmeyster N., Sarrouilhe D., and Duffy H.S. Gap junctional complexes: from partners to functions. Prog Biophys Mol Biol 94 (2007) 29-65
10. Kwak B.R., Mulhaupt F., Veillard N., Gros D.B., and Mach F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22 (2002) 225-230
11. Wayhs R., Zelinger A., and Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 39 (2002) 225-230
12. Budoff M.J., Ahmed V., Gul K.M., Mao S.S., and Gopal A. Coronary anomalies by cardiac computed tomographic angiography. Clin Cardiol 29 (2006) 489-493
13. Johnson R.C., Leopold J.A., and Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99 (2006) 1044-1059
14. Simon A.M., Goodenough D.A., Li E., and Paul D.L. Female infertility in mice lacking connexin 37. Nature 385 (1997) 525-529
15. Yang Y.H., Dudoit S., Luu P., et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30 4 (2002) e15
16. Cope L.M., Irizarry R.A., Jaffee H.A., Wu Z., and Speed T.P. A benchmark for Affymetrix GeneChip expression measures. Bioinformatics 20 (2004) 323-331
17. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3 (2004) Article3
18. Chadjichristos C.E., Matter C.M., Roth I., et al. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 113 (2006) 2835-2843
19. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 95 (2004) 1046-1057
20. Montecucco F., Steffens S., and Mach F. The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability?. Clin Dev Immunol 2007 (2007) 75805
21. Davies M.R., Lund R.J., and Hruska K.A. BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 14 (2003) 1559-1567
22. Chadjichristos C.E., Morel S., Derouette J.P., et al. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res 102 (2008) 653-660
23. McCormick M.M., Rahimi F., Bobryshev Y.V., et al. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem 280 (2005) 41521-41529
24. Anceriz N., Vandal K., and Tessier P.A. S100A9 mediates neutrophil adhesion to fibronectin through activation of beta2 integrins. Biochem Biophys Res Commun 354 (2007) 84-89
25. Healy A.M., Pickard M.D., Pradhan A.D., et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 113 (2006) 2278-2284
26. Jeng A.Y., Chou M., Sawyer W.K., et al. Enhanced expression of matrix metalloproteinase-3, -12, and -13 mRNAs in the aortas of apolipoprotein E-deficient mice with advanced atherosclerosis. Ann NY Acad Sci 878 (1999) 555-558
27. Deguchi J.O., Aikawa E., Libby P., et al. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 112 (2005) 2708-2715
28. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 69 (2006) 636-645
29. Yoon S., Kuivaniemi H., Gatalica Z., et al. MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males. Matrix Biol 21 (2002) 487-498
30. Brinckerhoff C.E., and Matrisian L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3 (2002) 207-214
31. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92 (2003) 827-839
32. Luttun A., Lutgens E., Manderveld A., et al. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 109 (2004) 1408-1414
33. Gough P.J., Gomez I.G., Wille P.T., and Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 116 (2006) 59-69
34. Rattazzi M., Bennett B.J., Bea F., et al. Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells. Arterioscler Thromb Vasc Biol 25 (2005) 1420-1425